z-logo
open-access-imgOpen Access
Omipalisib Inhibits Esophageal Squamous Cell Carcinoma Growth Through Inactivation of Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) and ERK Signaling
Author(s) -
Dongshan Zhu,
Jingyao Dong,
Yaoyao Xu,
Xintong Zhang,
Shibo Fu,
Wei Liu
Publication year - 2020
Publication title -
medical science monitor
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.636
H-Index - 85
eISSN - 1643-3750
pISSN - 1234-1010
DOI - 10.12659/msm.927106
Subject(s) - pi3k/akt/mtor pathway , protein kinase b , cell growth , cancer research , cell cycle , mapk/erk pathway , viability assay , biology , apoptosis , rptor , signal transduction , microbiology and biotechnology , biochemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom